{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,26]],"date-time":"2026-08-26T17:17:53Z","timestamp":1787764673905,"version":"build-2784847793"},"reference-count":68,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2019,7,23]],"date-time":"2019-07-23T00:00:00Z","timestamp":1563840000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2019,7,23]],"date-time":"2019-07-23T00:00:00Z","timestamp":1563840000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"Gunner and Ingmar Jungner Foundation for Laboratory Medicine","award":["3"],"award-info":[{"award-number":["3"]}]},{"DOI":"10.13039\/501100000764","name":"Kings College London","doi-asserted-by":"publisher","award":["1"],"award-info":[{"award-number":["1"]}],"id":[{"id":"10.13039\/501100000764","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004047","name":"Karolinska Institutet","doi-asserted-by":"publisher","award":["2"],"award-info":[{"award-number":["2"]}],"id":[{"id":"10.13039\/501100004047","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Mol and Cell Biol"],"published-print":{"date-parts":[[2019,12]]},"DOI":"10.1186\/s12860-019-0210-7","type":"journal-article","created":{"date-parts":[[2019,7,23]],"date-time":"2019-07-23T15:03:15Z","timestamp":1563894195000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":8,"title":["Metabolic profiles to predict long-term cancer and mortality: the use of latent class analysis"],"prefix":"10.1186","volume":"20","author":[{"given":"Aida","family":"Santaolalla","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hans","family":"Garmo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anita","family":"Grigoriadis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1932-0472","authenticated-orcid":false,"given":"Sundeep","family":"Ghuman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Niklas","family":"Hammar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ingmar","family":"Jungner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G\u00f6ran","family":"Walldius","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mats","family":"Lambe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lars","family":"Holmberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mieke","family":"Van Hemelrijck","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2019,7,23]]},"reference":[{"issue":"4","key":"210_CR1","doi-asserted-by":"publisher","first-page":"505","DOI":"10.1001\/jamaoncol.2015.0735","volume":"1","author":"C Fitzmaurice","year":"2015","unstructured":"Global Burden of Disease Cancer C, Fitzmaurice C, Dicker D, Pain A, Hamavid H, Moradi-Lakeh M, et al. The global burden of cancer 2013. JAMA Oncol. 2015;1(4):505\u201327 PubMed PMID: 26181261. Pubmed Central PMCID: 4500822.","journal-title":"JAMA Oncol"},{"issue":"1","key":"210_CR2","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1016\/S0092-8674(00)81683-9","volume":"100","author":"D Hanahan","year":"2000","unstructured":"Hanahan D, Weinberg RA. The hallmarks of cancer. Cell. 2000;100(1):57\u201370 PubMed PMID: 10647931.","journal-title":"Cell."},{"issue":"4","key":"210_CR3","doi-asserted-by":"publisher","first-page":"524","DOI":"10.1001\/jamaoncol.2016.5688","volume":"3","author":"C Fitzmaurice","year":"2017","unstructured":"Global Burden of Disease Cancer C, Fitzmaurice C, Allen C, Barber RM, Barregard L, Bhutta ZA, et al. Global, regional, and National Cancer Incidence, mortality, years of life lost, years lived with disability, and disability-adjusted life-years for 32 cancer groups, 1990 to 2015: a systematic analysis for the global burden of disease study. JAMA Oncol. 2017;3(4):524\u201348 PubMed PMID: 27918777.","journal-title":"JAMA Oncol"},{"key":"210_CR4","doi-asserted-by":"publisher","first-page":"227","DOI":"10.3389\/fphys.2012.00227","volume":"3","author":"RH Blair","year":"2012","unstructured":"Blair RH, Trichler DL, Gaille DP. Mathematical and statistical modeling in cancer systems biology. Front Physiol. 2012;3:227 PubMed PMID: 22754537. Pubmed Central PMCID: 3385354.","journal-title":"Front Physiol"},{"key":"210_CR5","doi-asserted-by":"crossref","unstructured":"Dupont WD, Blume JD, Smith JR. BUilding and validating complex models of breast cancer risk. JAMA Oncol. 2016;2(10):1271\u201372.","DOI":"10.1001\/jamaoncol.2016.0878"},{"issue":"7329","key":"210_CR6","doi-asserted-by":"publisher","first-page":"156","DOI":"10.1038\/469156a","volume":"469","author":"G Poste","year":"2011","unstructured":"Poste G. Bring on the biomarkers. Nature. 2011;469(7329):156\u20137 PubMed PMID: 21228852. Epub 2011\/01\/14. eng.","journal-title":"Nature."},{"issue":"6","key":"210_CR7","doi-asserted-by":"publisher","first-page":"928","DOI":"10.1373\/clinchem.2011.166058","volume":"57","author":"Y Zhang","year":"2011","unstructured":"Zhang Y. News & views: bring on the biomarkers\u2014It's time for the \u201cbig science\u201d approach. Clin Chem. 2011;57(6):928\u20139.","journal-title":"Clin Chem"},{"issue":"2","key":"210_CR8","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1101\/gr.124347.111","volume":"22","author":"JD Brooks","year":"2012","unstructured":"Brooks JD. Translational genomics: the challenge of developing cancer biomarkers. Genome Res. 2012;22(2):183\u20137 PubMed PMID: 22301132. Pubmed Central PMCID: 3266026.","journal-title":"Genome Res"},{"issue":"3","key":"210_CR9","doi-asserted-by":"publisher","first-page":"517","DOI":"10.1158\/1078-0432.CCR-12-1452","volume":"19","author":"H Beltran","year":"2013","unstructured":"Beltran H, Rubin MA. New strategies in prostate cancer: translating genomics into the clinic. Clin Cancer Res. 2013;19(3):517\u201323 PubMed PMID: 23248095. Epub 2012\/12\/19. eng.","journal-title":"Clin Cancer Res"},{"key":"210_CR10","doi-asserted-by":"publisher","first-page":"393","DOI":"10.1186\/1471-2407-12-393","volume":"12","author":"S B\u00fcnger","year":"2012","unstructured":"B\u00fcnger S, Haug U, Kelly M, Posorski N, Klempt-Giessing K, Cartwright A, et al. A novel multiplex-protein array for serum diagnostics of colon cancer: a case\u2013control study. BMC Cancer. 2012;12:393 PubMed PMID: PMC3502594.","journal-title":"BMC Cancer"},{"issue":"24","key":"210_CR11","doi-asserted-by":"publisher","first-page":"6111","DOI":"10.1158\/1078-0432.CCR-10-0119","volume":"16","author":"N Wild","year":"2010","unstructured":"Wild N, Andres H, Rollinger W, Krause F, Dilba P, Tacke M, et al. A combination of serum markers for the early detection of colorectal cancer. Clin Cancer Res. 2010;16(24):6111\u201321 PubMed PMID: 20798228. Epub 2010\/08\/28. eng.","journal-title":"Clin Cancer Res"},{"key":"210_CR12","unstructured":"Noto D, Cefalu AB, Barbagallo CM, Ganci A, Cavera G, Fayer F, et al. Baseline metabolic disturbances and the twenty-five years risk of incident cancer in a Mediterranean population. Nutr Metab Cardiovasc Dis. 2016;12 PubMed PMID: 27511705. Epub 2016\/08\/12. Eng."},{"issue":"5","key":"210_CR13","doi-asserted-by":"publisher","first-page":"844","DOI":"10.1016\/j.ahj.2012.02.005","volume":"163","author":"SH Shah","year":"2012","unstructured":"Shah SH, Sun JL, Stevens RD, Bain JR, Muehlbauer MJ, Pieper KS, et al. Baseline metabolomic profiles predict cardiovascular events in patients at risk for coronary artery disease. Am Heart J. 2012;163(5):844\u201350 e1. PubMed PMID: 22607863. Epub 2012\/05\/23. Eng.","journal-title":"Am Heart J"},{"issue":"1","key":"210_CR14","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1093\/ije\/dyr236","volume":"41","author":"CP Wild","year":"2012","unstructured":"Wild CP. The exposome: from concept to utility. Int J Epidemiol. 2012;41(1):24\u201332 PubMed PMID: 22296988. Epub 2012\/02\/03. Eng.","journal-title":"Int J Epidemiol"},{"issue":"7","key":"210_CR15","doi-asserted-by":"publisher","first-page":"480","DOI":"10.1002\/em.21777","volume":"54","author":"CP Wild","year":"2013","unstructured":"Wild CP, Scalbert A, Herceg Z. Measuring the exposome: a powerful basis for evaluating environmental exposures and cancer risk. Environ Mol Mutagen. 2013;54(7):480\u201399 PubMed PMID: 23681765. Epub 2013\/05\/18. eng.","journal-title":"Environ Mol Mutagen"},{"key":"210_CR16","doi-asserted-by":"publisher","first-page":"525","DOI":"10.1038\/msb.2011.57","volume":"7","author":"G Nicholson","year":"2011","unstructured":"Nicholson G, Rantalainen M, Maher AD, Li JV, Malmodin D, Ahmadi KR, et al. Human metabolic profiles are stably controlled by genetic and environmental variation. Mol Syst Biol. 2011;7:525 PubMed PMID: 21878913. Pubmed Central PMCID: PMC3202796. Epub 2011\/09\/01. Eng.","journal-title":"Mol Syst Biol"},{"issue":"8","key":"210_CR17","doi-asserted-by":"publisher","first-page":"A137","DOI":"10.1289\/EHP412","volume":"124","author":"Y Cui","year":"2016","unstructured":"Cui Y, Balshaw DM, Kwok RK, Thompson CL, Collman GW, Birnbaum LS. The Exposome: embracing the complexity for discovery in environmental health. Environ Health Perspect. 2016;124(8):A137\u201340 PubMed PMID: 27479988. Pubmed Central PMCID: PMC4977033. Epub 2016\/08\/02. eng.","journal-title":"Environ Health Perspect"},{"issue":"2","key":"210_CR18","doi-asserted-by":"publisher","first-page":"260","DOI":"10.1002\/ijc.10332","volume":"99","author":"K Czene","year":"2002","unstructured":"Czene K, Lichtenstein P, Hemminki K. Environmental and heritable causes of cancer among 9.6 million individuals in the Swedish family-cancer database. Int J Cancer. 2002;99(2):260\u20136 PubMed PMID: 11979442. Epub 2002\/04\/30. Eng.","journal-title":"Int J Cancer"},{"key":"210_CR19","first-page":"35","volume":"4","author":"G Walldius","year":"1992","unstructured":"Walldius G, Jungner I, Kolar W, Holme I, Steiner E. High cholesterol and triglyceride values in Swedish males and females: increased risk of fatal myocardial infarction. First report from the AMORIS (apolipoprotein related MOrtality RISk) study. Blood Press Suppl. 1992;4:35\u201342 PubMed PMID: 1345333. Epub 1992\/01\/01. eng.","journal-title":"Blood Press Suppl"},{"issue":"9298","key":"210_CR20","doi-asserted-by":"publisher","first-page":"2026","DOI":"10.1016\/S0140-6736(01)07098-2","volume":"358","author":"G Walldius","year":"2001","unstructured":"Walldius G, Jungner I, Holme I, Aastveit AH, Kolar W, Steiner E. High apolipoprotein B, low apolipoprotein A-I, and improvement in the prediction of fatal myocardial infarction (AMORIS study): a prospective study. Lancet. 2001;358(9298):2026\u201333 PubMed PMID: 11755609. Epub 2002\/01\/05. eng.","journal-title":"Lancet."},{"key":"210_CR21","doi-asserted-by":"publisher","unstructured":"Lacey RJ, Strauss VY, Rathod T, et al. Clustering of pain and its associations with health in people aged 50 years and older: cross-sectional results from the North Staffordshire Osteoarthritis Project. BMJ Open. 2015;5:e008389. doi: https:\/\/doi.org\/10.1136\/bmjopen-2015-008389 .","DOI":"10.1136\/bmjopen-2015-008389"},{"issue":"1","key":"210_CR22","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1093\/ije\/dyi056","volume":"34","author":"H Tolonen","year":"2005","unstructured":"Tolonen H, Keil U, Ferrario M, Evans A, Project WM. Prevalence, awareness and treatment of hypercholesterolaemia in 32 populations: results from the WHO MONICA Project. Int J Epidemiol. 2005;34(1):181\u201392 PubMed PMID: 15333620.","journal-title":"Int J Epidemiol"},{"key":"210_CR23","unstructured":"Reiner \u017d, Catapano AL, De Backer G, Graham I, Taskinen M-R, Wiklund O, et al. ESC\/EAS guidelines for the management of dyslipidaemias. The task force for the management of dyslipidaemias of the European Society of Cardiology (ESC) and the European atherosclerosis society (EAS). Eur Heart J. 2016;37(39):2999\u20133058."},{"issue":"1","key":"210_CR24","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1111\/j.1572-0241.2005.00341.x","volume":"101","author":"GN Ioannou","year":"2006","unstructured":"Ioannou GN, Boyko EJ, Lee SP. The prevalence and predictors of elevated serum aminotransferase activity in the United States in 1999-2002. Am J Gastroenterol. 2006;101(1):76\u201382 PubMed PMID: 16405537. Epub 2006\/01\/13. eng.","journal-title":"Am J Gastroenterol"},{"issue":"1","key":"210_CR25","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1111\/j.1751-7141.2009.00054.x","volume":"13","author":"JE Mason","year":"2010","unstructured":"Mason JE, Starke RD, Van Kirk JE. Gamma-glutamyl transferase: a novel cardiovascular risk biomarker. Prev Cardiol. 2010;13(1):36\u201341 PubMed PMID: 20021625. Epub 2009\/12\/22. eng.","journal-title":"Prev Cardiol"},{"issue":"1","key":"210_CR26","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1159\/000274463","volume":"33","author":"S Teppala","year":"2010","unstructured":"Teppala S, Shankar A, Li J, Wong TY, Ducatman A. Association between serum gamma-glutamyltransferase and chronic kidney disease among US adults. Kidney Blood Press Res. 2010;33(1):1\u20136 PubMed PMID: 20090360. Epub 2010\/01\/22. eng.","journal-title":"Kidney Blood Press Res"},{"issue":"7","key":"210_CR27","doi-asserted-by":"publisher","first-page":"1018","DOI":"10.1016\/j.freeradbiomed.2004.06.032","volume":"37","author":"JS Lim","year":"2004","unstructured":"Lim JS, Yang JH, Chun BY, Kam S, Jacobs DR Jr, Lee DH. Is serum gamma-glutamyltransferase inversely associated with serum antioxidants as a marker of oxidative stress? Free Radic Biol Med. 2004;37(7):1018\u201323 PubMed PMID: 15336318. Epub 2004\/09\/01. eng.","journal-title":"Free Radic Biol Med"},{"key":"210_CR28","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1146\/annurev.nutr.012809.104804","volume":"30","author":"M Wessling-Resnick","year":"2010","unstructured":"Wessling-Resnick M. Iron homeostasis and the inflammatory response. Annu Rev Nutr. 2010;30:105\u201322 PubMed PMID: PMC3108097.","journal-title":"Annu Rev Nutr"},{"issue":"8","key":"210_CR29","doi-asserted-by":"publisher","first-page":"769","DOI":"10.1289\/ehp.1308015","volume":"122","author":"SM Rappaport","year":"2014","unstructured":"Rappaport SM, Barupal DK, Wishart D, Vineis P, Scalbert A. The blood exposome and its role in discovering causes of disease. Environ Health Perspect. 2014;122(8):769\u201374 PubMed PMID: 24659601. Pubmed Central PMCID: 4123034.","journal-title":"Environ Health Perspect"},{"issue":"13","key":"210_CR30","doi-asserted-by":"publisher","first-page":"2033","DOI":"10.1016\/j.ejca.2011.03.010","volume":"47","author":"M Van Hemelrijck","year":"2011","unstructured":"Van Hemelrijck M, Jassem W, Walldius G, Fentiman IS, Hammar N, Lambe M, et al. Gamma-glutamyltransferase and risk of cancer in a cohort of 545,460 persons - the Swedish AMORIS study. Eur J Cancer. 2011;47(13):2033\u201341 PubMed PMID: 21486691. Epub 2011\/04\/14. eng.","journal-title":"Eur J Cancer"},{"issue":"10","key":"210_CR31","doi-asserted-by":"publisher","first-page":"3970","DOI":"10.1158\/0008-5472.CAN-07-6686","volume":"68","author":"AM Strasak","year":"2008","unstructured":"Strasak AM, Rapp K, Brant LJ, Hilbe W, Gregory M, Oberaigner W, et al. Association of gamma-glutamyltransferase and risk of cancer incidence in men: a prospective study. Cancer Res. 2008;68(10):3970\u20137 PubMed PMID: 18483283. Epub 2008\/05\/17. eng.","journal-title":"Cancer Res"},{"issue":"8","key":"210_CR32","doi-asserted-by":"publisher","first-page":"1902","DOI":"10.1002\/ijc.23714","volume":"123","author":"AM Strasak","year":"2008","unstructured":"Strasak AM, Pfeiffer RM, Klenk J, Hilbe W, Oberaigner W, Gregory M, et al. Prospective study of the association of gamma-glutamyltransferase with cancer incidence in women. Int J Cancer. 2008;123(8):1902\u20136 PubMed PMID: 18688855. Epub 2008\/08\/09. eng.","journal-title":"Int J Cancer"},{"issue":"2","key":"210_CR33","doi-asserted-by":"publisher","first-page":"477","DOI":"10.1053\/j.gastro.2008.10.052","volume":"136","author":"CE Ruhl","year":"2009","unstructured":"Ruhl CE, Everhart JE. Elevated serum alanine aminotransferase and gamma-glutamyltransferase and mortality in the United States population. Gastroenterology. 2009;136(2):477\u201385 e11. PubMed PMID: 19100265. Epub 2008\/12\/23. eng.","journal-title":"Gastroenterology."},{"issue":"2","key":"210_CR34","doi-asserted-by":"publisher","first-page":"296","DOI":"10.1111\/liv.12311","volume":"34","author":"EM Koehler","year":"2014","unstructured":"Koehler EM, Sanna D, Hansen BE, van Rooij FJ, Heeringa J, Hofman A, et al. Serum liver enzymes are associated with all-cause mortality in an elderly population. Liver Int. 2014;34(2):296\u2013304 PubMed PMID: 24219360. Epub 2013\/11\/14. eng.","journal-title":"Liver Int"},{"issue":"1","key":"210_CR35","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1093\/ije\/dyt192","volume":"43","author":"SK Kunutsor","year":"2014","unstructured":"Kunutsor SK, Apekey TA, Seddoh D, Walley J. Liver enzymes and risk of all-cause mortality in general populations: a systematic review and meta-analysis. Int J Epidemiol. 2014;43(1):187\u2013201.","journal-title":"Int J Epidemiol"},{"issue":"8167","key":"210_CR36","doi-asserted-by":"publisher","first-page":"523","DOI":"10.1016\/S0140-6736(80)92775-0","volume":"1","author":"G Rose","year":"1980","unstructured":"Rose G, Shipley MJ. Plasma lipids and mortality: a source of error. Lancet. 1980;1(8167):523\u20136 PubMed PMID: 6102243. Epub 1980\/03\/08. eng.","journal-title":"Lancet."},{"issue":"2","key":"210_CR37","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1111\/j.1532-5415.2005.53106.x","volume":"53","author":"N Schupf","year":"2005","unstructured":"Schupf N, Costa R, Luchsinger J, Tang MX, Lee JH, Mayeux R. Relationship between plasma lipids and all-cause mortality in nondemented elderly. J Am Geriatr Soc. 2005;53(2):219\u201326 PubMed PMID: 15673344. Epub 2005\/01\/28. eng.","journal-title":"J Am Geriatr Soc"},{"issue":"2","key":"210_CR38","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1093\/ageing\/afn017","volume":"37","author":"JL Akerblom","year":"2008","unstructured":"Akerblom JL, Costa R, Luchsinger JA, Manly JJ, Tang M-X, Lee JH, et al. Relation of plasma lipids to all-cause mortality in Caucasian, African-American and Hispanic elders. Age Ageing. 2008;37(2):207\u201313 PubMed PMID: PMC2715146.","journal-title":"Age Ageing"},{"issue":"7","key":"210_CR39","doi-asserted-by":"publisher","first-page":"1490","DOI":"10.1001\/archinte.1992.00400190110021","volume":"152","author":"JD Neaton","year":"1992","unstructured":"Neaton JD, Blackburn H, Jacobs D, et al. Serum cholesterol level and mortality findings for men screened in the multiple risk factor intervention trial. Arch Intern Med. 1992;152(7):1490\u2013500.","journal-title":"Arch Intern Med"},{"issue":"1","key":"210_CR40","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1093\/oxfordjournals.aje.a113157","volume":"114","author":"A Kagan","year":"1981","unstructured":"Kagan A, McGee DL, Yano K, Rhoads GG, Nomura A. Serum cholesterol and mortality in a Japanese-American population: the Honolulu heart program. Am J Epidemiol. 1981;114(1):11\u201320 PubMed PMID: 7246518. Epub 1981\/07\/01. eng.","journal-title":"Am J Epidemiol"},{"issue":"2","key":"210_CR41","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1016\/j.medici.2016.03.002","volume":"52","author":"R Radi\u0161auskas","year":"2016","unstructured":"Radi\u0161auskas R, Kuzmickien\u0117 I, Milinavi\u010dien\u0117 E, Everatt R. Hypertension, serum lipids and cancer risk: a review of epidemiological evidence. Medicina (Mex). 2016;52(2):89\u201398.","journal-title":"Medicina (Mex)"},{"issue":"7","key":"210_CR42","doi-asserted-by":"publisher","first-page":"1393","DOI":"10.1007\/s10552-013-0219-8","volume":"24","author":"A Gaur","year":"2013","unstructured":"Gaur A, Collins H, Wulaningsih W, Holmberg L, Garmo H, Hammar N, et al. Iron metabolism and risk of cancer in the Swedish AMORIS study. Cancer Causes Control. 2013;24(7):1393\u2013402 PubMed PMID: 23649231. Pubmed Central PMCID: PMC3675271. Epub 2013\/05\/08. eng.","journal-title":"Cancer Causes Control"},{"issue":"1","key":"210_CR43","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.critrevonc.2013.10.008","volume":"89","author":"Y Beguin","year":"2014","unstructured":"Beguin Y, Aapro M, Ludwig H, Mizzen L, Osterborg A. Epidemiological and nonclinical studies investigating effects of iron in carcinogenesis--a critical review. Crit Rev Oncol Hematol. 2014;89(1):1\u201315 PubMed PMID: 24275533.","journal-title":"Crit Rev Oncol Hematol"},{"issue":"5","key":"210_CR44","doi-asserted-by":"publisher","first-page":"782","DOI":"10.1002\/sim.6793","volume":"35","author":"M Wang","year":"2016","unstructured":"Wang M, Spiegelman D, Kuchiba A, Lochhead P, Kim S, Chan AT, et al. Statistical methods for studying disease subtype heterogeneity. Stat Med. 2016;35(5):782\u2013800 PubMed PMID: 26619806. Pubmed Central PMCID: 4728021. Epub 2015\/12\/02. eng.","journal-title":"Stat Med"},{"issue":"5","key":"210_CR45","doi-asserted-by":"publisher","first-page":"1304","DOI":"10.3945\/ajcn.110.005892","volume":"94","author":"V Chaj\u00e8s","year":"2011","unstructured":"Chaj\u00e8s V, Jenab M, Romieu I, Ferrari P, Dahm CC, Overvad K, et al. Plasma phospholipid fatty acid concentrations and risk of gastric adenocarcinomas in the European prospective investigation into cancer and nutrition (EPIC-EURGAST). Am J Clin Nutr. 2011;94(5):1304\u201313.","journal-title":"Am J Clin Nutr"},{"issue":"6","key":"210_CR46","doi-asserted-by":"publisher","first-page":"535","DOI":"10.1289\/ehp.1307204","volume":"122","author":"M Vrijheid","year":"2014","unstructured":"Vrijheid M, Slama R, Robinson O, Chatzi L, Coen M, van den Hazel P, et al. The human early-life exposome (HELIX): project rationale and design. Environ Health Perspect. 2014;122(6):535\u201344 PubMed PMID: 24610234. Pubmed Central PMCID: PMC4048258. Epub 2014\/03\/13. eng.","journal-title":"Environ Health Perspect"},{"issue":"1","key":"210_CR47","first-page":"66","volume":"3","author":"M Van Hemelrijck","year":"2012","unstructured":"Van Hemelrijck M, Harari D, Garmo H, Hammar N, Walldius G, Lambe M, et al. Biomarker-based score to predict mortality in persons aged 50 years and older: a new approach in the Swedish AMORIS study. Int J Mol Epidemiol Genet. 2012;3(1):66\u201376 PubMed PMID: 22493753. Pubmed Central PMCID: 3316450. Epub 2012\/04\/12. eng.","journal-title":"Int J Mol Epidemiol Genet"},{"key":"210_CR48","unstructured":"Walldius G, Malmstrom H, Jungner I, de Faire U, Lambe M, Van Hemelrijck M, et al. The AMORIS cohort. Int J Epidemiol. 2017;02 PubMed PMID: 28158674. Epub 2017\/02\/06. eng."},{"issue":"8 Pt 1","key":"210_CR49","doi-asserted-by":"crossref","first-page":"1641","DOI":"10.1093\/clinchem\/44.8.1641","volume":"44","author":"I Jungner","year":"1998","unstructured":"Jungner I, Marcovina SM, Walldius G, Holme I, Kolar W, Steiner E. Apolipoprotein B and A-I values in 147576 Swedish males and females, standardized according to the World Health Organization-International Federation of Clinical Chemistry First International Reference Materials. Clin Chem. 1998;44(8 Pt 1):1641\u20139 PubMed PMID: 9702950. Epub 1998\/08\/14. eng.","journal-title":"Clin Chem"},{"issue":"7","key":"210_CR50","doi-asserted-by":"publisher","first-page":"1011","DOI":"10.1007\/s10552-011-9774-z","volume":"22","author":"M Van Hemelrijck","year":"2011","unstructured":"Van Hemelrijck M, Walldius G, Jungner I, Hammar N, Garmo H, Binda E, et al. Low levels of apolipoprotein A-I and HDL are associated with risk of prostate cancer in the Swedish AMORIS study. Cancer Causes Contr. 2011;22(7):1011\u20139 PubMed PMID: 21562751. Epub 2011\/05\/13. eng.","journal-title":"Cancer Causes Contr"},{"issue":"10","key":"210_CR51","doi-asserted-by":"publisher","first-page":"2086","DOI":"10.1002\/cncr.25758","volume":"117","author":"M Van Hemelrijck","year":"2011","unstructured":"Van Hemelrijck M, Garmo H, Holmberg L, Walldius G, Jungner I, Hammar N, et al. Prostate cancer risk in the Swedish AMORIS study: the interplay among triglycerides, total cholesterol, and glucose. Cancer. 2011;117(10):2086\u201395 PubMed PMID: 21523720. Epub 2011\/04\/28. eng.","journal-title":"Cancer."},{"issue":"3","key":"210_CR52","doi-asserted-by":"publisher","first-page":"428","DOI":"10.1158\/1055-9965.EPI-10-1190","volume":"20","author":"M Van Hemelrijck","year":"2011","unstructured":"Van Hemelrijck M, Holmberg L, Garmo H, Hammar N, Walldius G, Binda E, et al. Association between levels of C-reactive protein and leukocytes and cancer: three repeated measurements in the Swedish AMORIS study. Cancer Epidemiol Biomark Prev. 2011;20(3):428\u201337 PubMed PMID: 21297038. Pubmed Central PMCID: PMC3078551. Epub 2011\/02\/08. eng.","journal-title":"Cancer Epidemiol Biomark Prev"},{"issue":"8","key":"210_CR53","doi-asserted-by":"publisher","first-page":"1381","DOI":"10.1158\/1055-9965.EPI-12-0188","volume":"21","author":"JC Melvin","year":"2012","unstructured":"Melvin JC, Seth D, Holmberg L, Garmo H, Hammar N, Jungner I, et al. Lipid profiles and risk of breast and ovarian cancer in the Swedish AMORIS study. Cancer Epidemiol Biomark Prev. 2012;21(8):1381\u20134 PubMed PMID: 22593241. Epub 2012\/05\/18. eng.","journal-title":"Cancer Epidemiol Biomark Prev"},{"issue":"9","key":"210_CR54","doi-asserted-by":"publisher","first-page":"2118","DOI":"10.1002\/ijc.26212","volume":"130","author":"M Van Hemelrijck","year":"2012","unstructured":"Van Hemelrijck M, Garmo H, Hammar N, Jungner I, Walldius G, Lambe M, et al. The interplay between lipid profiles, glucose, BMI and risk of kidney cancer in the Swedish AMORIS study. Int J Cancer. 2012;130(9):2118\u201328 PubMed PMID: 21630265. Epub 2011\/06\/02. eng.","journal-title":"Int J Cancer"},{"key":"210_CR55","doi-asserted-by":"publisher","first-page":"792034","DOI":"10.1155\/2012\/792034","volume":"2012","author":"W Wulaningsih","year":"2012","unstructured":"Wulaningsih W, Garmo H, Holmberg L, Hammar N, Jungner I, Walldius G, et al. Serum lipids and the risk of gastrointestinal malignancies in the Swedish AMORIS study. J Cancer Epidemiol. 2012;2012:792034 PubMed PMID: 22969802. Pubmed Central PMCID: 3437288.","journal-title":"J Cancer Epidemiol"},{"issue":"8","key":"210_CR56","doi-asserted-by":"publisher","first-page":"1349","DOI":"10.1007\/s10552-012-0015-x","volume":"23","author":"M Van Hemelrijck","year":"2012","unstructured":"Van Hemelrijck M, Hermans R, Michaelsson K, Melvin J, Garmo H, Hammar N, et al. Serum calcium and incident and fatal prostate cancer in the Swedish AMORIS study. Cancer Causes Contr. 2012;23(8):1349\u201358 PubMed PMID: 22710746. Epub 2012\/06\/20. eng.","journal-title":"Cancer Causes Contr"},{"key":"210_CR57","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1186\/1471-2407-13-257","volume":"13","author":"W Wulaningsih","year":"2013","unstructured":"Wulaningsih W, Michaelsson K, Garmo H, Hammar N, Jungner I, Walldius G, et al. Inorganic phosphate and the risk of cancer in the Swedish AMORIS study. BMC Cancer. 2013;13:257 PubMed PMID: 23706176. Pubmed Central PMCID: PMC3664604. Epub 2013\/05\/28. eng.","journal-title":"BMC Cancer"},{"issue":"1","key":"210_CR58","doi-asserted-by":"publisher","first-page":"663","DOI":"10.1186\/1471-2458-13-663","volume":"13","author":"W Wulaningsih","year":"2013","unstructured":"Wulaningsih W, Michaelsson K, Garmo H, Hammar N, Jungner I, Walldius G, et al. Serum calcium and risk of gastrointestinal cancer in the Swedish AMORIS study. BMC Public Health. 2013;13(1):663 PubMed PMID: 23866097. Pubmed Central PMCID: 3729677. Epub 2013\/07\/20. Eng.","journal-title":"BMC Public Health"},{"issue":"1","key":"210_CR59","doi-asserted-by":"publisher","first-page":"e54944","DOI":"10.1371\/journal.pone.0054944","volume":"8","author":"W Wulaningsih","year":"2013","unstructured":"Wulaningsih W, Holmberg L, Garmo H, Zethelius B, Wigertz A, Carroll P, et al. Serum glucose and fructosamine in relation to risk of cancer. PLoS One. 2013;8(1):e54944 PubMed PMID: 23372798. Pubmed Central PMCID: PMC3556075. Epub 2013\/02\/02. eng.","journal-title":"PLoS One"},{"issue":"6","key":"210_CR60","doi-asserted-by":"publisher","first-page":"676","DOI":"10.1093\/aje\/kwq433","volume":"173","author":"H Quan","year":"2011","unstructured":"Quan H, Li B, Couris CM, Fushimi K, Graham P, Hider P, et al. Updating and validating the Charlson comorbidity index and score for risk adjustment in hospital discharge abstracts using data from 6 countries. Am J Epidemiol. 2011;173(6):676\u201382 PubMed PMID: 21330339.","journal-title":"Am J Epidemiol"},{"issue":"5","key":"210_CR61","doi-asserted-by":"publisher","first-page":"313","DOI":"10.1016\/0009-9120(92)80004-Z","volume":"25","author":"JM Kuyl","year":"1992","unstructured":"Kuyl JM, Mendelsohn D. Observed relationship between ratios HDL-cholesterol\/total cholesterol and apolipoprotein A1\/apolipoprotein B. Clin Biochem. 1992;25(5):313\u20136 PubMed PMID: 1490290. Epub 1992\/10\/01. eng.","journal-title":"Clin Biochem"},{"issue":"7","key":"210_CR62","doi-asserted-by":"publisher","first-page":"583","DOI":"10.1016\/S0009-9120(01)00263-6","volume":"34","author":"M Dobi\u00e1sov\u00e1","year":"2001","unstructured":"Dobi\u00e1sov\u00e1 M, Frohlich J. The plasma parameter log (TG\/HDL-C) as an atherogenic index: correlation with lipoprotein particle size and esterification rate inapob-lipoprotein-depleted plasma (FERHDL). Clin Biochem. 2001;34(7):583\u20138.","journal-title":"Clin Biochem"},{"key":"210_CR63","doi-asserted-by":"crossref","unstructured":"Magidson J, Vermunt JK. \u201cLatent class models\u201d. The Sage handbook of quantitative methodology for the social sciences. 2004:175\u201398.","DOI":"10.4135\/9781412986311.n10"},{"issue":"1","key":"210_CR64","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1007\/s00357-008-9011-y","volume":"25","author":"PK Wood","year":"2008","unstructured":"Wood PK, Hagenaars JA, McCutcheon AL. Applied latent class analysis, Kluwer, Dordrecht, 2002, pp. 476. J Classif. 2008;25(1):143\u20135 English.","journal-title":"J Classif"},{"issue":"7","key":"210_CR65","doi-asserted-by":"publisher","first-page":"542","DOI":"10.1002\/em.21797","volume":"54","author":"M Chadeau-Hyam","year":"2013","unstructured":"Chadeau-Hyam M, Campanella G, Jombart T, Bottolo L, Portengen L, Vineis P, et al. Deciphering the complex: methodological overview of statistical models to derive OMICS-based biomarkers. Environ Mol Mutagen. 2013;54(7):542\u201357.","journal-title":"Environ Mol Mutagen"},{"key":"210_CR66","unstructured":"Kongsted A, Nielsen AM. Latent class analysis in health research. J Phys. 2016;12 PubMed PMID: 27914733. Epub 2016\/12\/05. eng."},{"key":"210_CR67","doi-asserted-by":"crossref","unstructured":"Haughton D, Legrand P, Woolford S. Review of three latent class cluster analysis packages: latent gold, poLCA, and MCLUST. Am Stat. 2009;63(1).","DOI":"10.1198\/tast.2009.0016"},{"key":"210_CR68","doi-asserted-by":"publisher","unstructured":"Lewis JB, Linzer DA. poLCA: An R Package for Polytomous Variable Latent Class Analysis. J Stat Softw. 2011;42. https:\/\/doi.org\/10.18637\/jss.v042.i10 .","DOI":"10.18637\/jss.v042.i10"}],"container-title":["BMC Molecular and Cell Biology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12860-019-0210-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s12860-019-0210-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12860-019-0210-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,9,24]],"date-time":"2022-09-24T11:51:48Z","timestamp":1664020308000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcmolcellbiol.biomedcentral.com\/articles\/10.1186\/s12860-019-0210-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,7,23]]},"references-count":68,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2019,12]]}},"alternative-id":["210"],"URL":"https:\/\/doi.org\/10.1186\/s12860-019-0210-7","relation":{},"ISSN":["2661-8850"],"issn-type":[{"value":"2661-8850","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,7,23]]},"assertion":[{"value":"12 March 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 July 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 July 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The study was approved by the ethics board of Karolinska Institutet who waived the need for consent and conformed to the declaration of Helsinki.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"The authors declare that they have no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"28"}}